REG - Spectra Systems Spectra Systems-SPSC - Exercise of Options

Spectra SystemsAnnouncement

09/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250109:nRSI6585Sa&default-theme=true

RNS Number : 6585S  Spectra Systems Corporation  09 January 2025

Spectra Systems Corporation

(the "Company")

Exercise of Options

Spectra Systems Corporation, a leader in machine-readable high speed banknote
authentication, brand protection technologies, and gaming security software,
announces the exercise of options by an employee of Spectra.

The employee has exercised options over 20,000 shares of common stock of $0.01
each in the Company ("Shares") with an exercise price of US$ 1.54 per share on
7 January 2025. The employee has elected to utilize the net cashless exercise
feature and has therefore surrendered 7,996 shares to the Company.
Accordingly, the employee will be issued 12,004 shares.

The shares being issued are restricted securities as defined in Rule 144 of
the US Securities Act of 1933 and have been issued pursuant to an exemption
from registration under Rule 701 promulgated under the US Securities Act of
1933.

Accordingly, the Company has issued and will apply for 12,004 Shares to be
admitted to trading on AIM, which is expected to take place on or around 14
January 2025 ("Admission").The Company's issued share capital now comprises:

583,384 shares in the Regulation S stock line ISIN number USU8457D1091
(AIM:SPSC); and

47,669,592 shares in the unrestricted line ISIN number US84756T1060
(AIM:SPSY).

Spectra Systems has no Shares in treasury, therefore 48,252,976 may be used
by shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change in
their interest in, the share capital of the Company under the
FCA's Disclosure and Transparency Rules.

Enquiries:

 

 

 Spectra Systems Corporation                          Tel: +1 (0)401 274 4700

 Dr. Nabil Lawandy, Chief Executive Officer

 Zeus (Nominated Adviser and Broker)                  Tel: +44 (0)20 3829 5000

 Chris Fielding (Director, Investment Banking)

 James Bavister (Assistant Director)

 Andrew de Andrade (Associate, Corporate Finance)

                                                      Tel: +44 (0)20 3328 5665

 Allenby Capital Limited (Joint Broker)

 Nick Naylor/James Reeve (Corporate Finance)

 Amrit Nahal (Sales and Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFLFETLLITIIE